CODX
$2.29
Co-Diagnostics, Inc.
Recent News
Auna S.A. (AUNA) Tops Q4 Earnings and Revenue Estimates
Auna S.A. (AUNA) delivered earnings and revenue surprises of +324.00% and +1.92%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Will Community Health's $450M Hospital Divestment Reduce Debt Burden?
CYH plans to sell Crestwood Medical Center for $450M, a deal topping its market value and aimed at easing the hospital operator's heavy debt load.
Co-Diagnostics announces 1-for-30 reverse stock split
Co-Diagnostics (CODX) announced that it has filed a Certificate of Amendment to its Certificate of Incorporation to effect a reverse stock split of its common stock at a ratio of 1-for-30 shares. The reverse stock split will become effective at 12:01 a.m. ET on Friday, January 2, 2026. Co-Dx’s common stock will continue to trade on The Nasdaq Capital Market under the symbol “CODX” and will begin trading on a split-adjusted basis when the market opens on Friday, January 2, 2026. The reverse stock
CoDiagnostics (CODX) Upgraded to Buy: Here's What You Should Know
CoDiagnostics (CODX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Co-Diagnostics Inc (CODX) Q3 2025 Earnings Call Highlights: Strategic Ventures and Financial ...
Co-Diagnostics Inc (CODX) explores new joint ventures and strategic alternatives amid revenue decline and financial restructuring.